Earnings Call · Q3 FY2022·2022-11-08

Q3 22EPS -7.55%·Rev n/aQ2 22EPS -10.00%·Rev n/aQ1 22EPS +14.63%·Rev n/aQ4 21EPS -29.73%·Rev n/a⚠ consensus missing

Xenon Pharmaceuticals Inc. XENE

Sherry Aulin — Chief Financial Officer

Ian Mortimer — President and Chief Executive Officer

Chris Kenney — Chief Medical Officer

−6.6%1d on move date−4.5% vs SPY3d−2.8%5d−1.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more XENE calls or request research access.

More XENE calls Browse calls Request research access